The new biotech is developing an antibody-oligo conjugate platform that uses "brain shuttles" to deliver drugs across the blood-brain barrier.

The study found that patients with luminal B subtype prostate cancer benefited from the addition of hormone therapy to ...

The drugmaker is transitioning to Trialbee's Honey platform to better screen patients, including for biomarker information, ...

The firm is testing the modified nucleotide drug ateganosine in a Phase II study with a PD-1 inhibitor in patients with non-small cell lung cancer.

VRise will develop and commercialize in India the BCMA/CD19-targeted KQ-2003, which is being studied as a treatment for multiple myeloma and POEMS syndrome.

Half of US commercial health plans add coverage limits for gene and cell therapies beyond what they're approved for, ...

By leveraging EEG biomarkers, Alto Neuroscience seeks to target patient subgroups in psychiatry by matching therapies to biology.

In the meeting, the firm will discuss with the agency new, positive three-month data from the pediatric cohort of the Phase I/II OPGx-LCA5-1001 trial.

The development partners said they will share data with regulators, and AstraZeneca said it will harmonize its share listing across international stock exchanges.

In an increasingly crowded space, the firm is using streamlined manufacturing and lipid nanoparticle delivery for its in vivo ...

Retrospective research from more than a decade ago demonstrated the potential benefit, but it hadn't been confirmed in a ...